Menopause, a natural phase in a woman’s life, may soon be preventable with the development of a new drug. Researchers at the biotech company Oviva Therapeutics in New York claim to have created an injection that could potentially delay the onset of menopause indefinitely. This breakthrough could offer relief from the uncomfortable symptoms associated with menopause, such as hot flashes, night sweats, and mood changes.

The drug works by increasing levels of anti-Mullerian hormone (AMH), which is produced in the ovaries and plays a role in ovulation. According to Dr. Daisy Robinton, a molecular biologist at Oviva Therapeutics, the injection could not only delay menopause but also prevent it from occurring altogether. She presented her team’s findings at the Livelong Summit in Florida, stating that the drug could slow the loss of ovarian reserve and extend the runway to menopause.

While the drug is currently being tested for safety in rodents, it may undergo human trials in the future if proven successful. However, if approved for use in humans, the treatment could be costly, potentially reaching six figures due to the expensive research involved.

Although the researchers have not highlighted any adverse effects associated with the injection, it’s important to note that hormone replacement therapy, which is commonly used to relieve menopausal symptoms, has been linked to increased risks of cancer, blood clots, and stroke. Dr. Robinton emphasized the significance of the hormones produced by a woman’s body, stating that they provide a consistent quality of life during her reproductive years.

The potential impact of this new drug goes beyond fertility, as it could significantly improve the overall health and well-being of women. As the research progresses, it offers hope for a future where women have more control over their reproductive health and the symptoms associated with menopause.